We are live on ! Find out more
HQY icon

HealthEquity

298 hedge funds and large institutions have $5.63B invested in HealthEquity in 2022 Q1 according to their latest regulatory filings, with 64 funds opening new positions, 110 increasing their positions, 94 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more call options, than puts

Call options by funds: $33.9M | Put options by funds: $19.9M

56% more capital invested

Capital invested by funds: $3.6B → $5.63B (+$2.03B)

45% more first-time investments, than exits

New positions opened: 64 | Existing positions closed: 44

17% more repeat investments, than reductions

Existing positions increased: 110 | Existing positions reduced: 94

6% more funds holding

Funds holding: 282298 (+16)

2.57% more ownership

Funds ownership: 97.51%100.08% (+2.6%)

Holders
298
Holders Change
+16
Holders Change %
+5.67%
% of All Funds
4.7%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.06%
New
64
Increased
110
Reduced
94
Closed
44
Calls
$33.9M
Puts
$19.9M
Net Calls
+$14M
Net Calls Change
+$21.9M
Name Holding Trade Value Shares
Change
Change in
Stake
GKIM
26
GW&K Investment Management
Massachusetts
$54.4M +$2.52M +46,645 +6%
BAMCO Inc
27
BAMCO Inc
New York
$54M
Massachusetts Financial Services
28
Massachusetts Financial Services
Massachusetts
$53.9M +$1.12M +20,811 +3%
Dimensional Fund Advisors
29
Dimensional Fund Advisors
Texas
$47.2M +$8.62M +159,630 +30%
KCM
30
Kornitzer Capital Management
Kansas
$41.3M
Allspring Global Investments
31
Allspring Global Investments
North Carolina
$40.7M +$210K +3,891 +0.6%
ACB
32
Aristotle Capital Boston
Massachusetts
$38.8M -$705K -13,052 -2%
N
33
Nuveen
North Carolina
$38.6M -$4.67M -86,479 -11%
AAM
34
Aureus Asset Management
Massachusetts
$34.4M +$6.55M +121,315 +31%
Norges Bank
35
Norges Bank
Norway
$33.2M -$380K -7,033 -1%
GIP
36
Granite Investment Partners
California
$32.9M +$22.2M +410,710 +532%
ITP
37
Iron Triangle Partners
Connecticut
$32.8M +$26.3M +486,862 New
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$31.2M -$9.76M -180,720 -28%
D.E. Shaw & Co
39
D.E. Shaw & Co
New York
$30.2M -$883K -16,343 -4%
American Century Companies
40
American Century Companies
Missouri
$29.5M -$496K -9,194 -2%
ClearBridge Investments
41
ClearBridge Investments
New York
$28.2M +$171K +3,170 +0.8%
Bank of America
42
Bank of America
North Carolina
$27.2M +$5.8M +107,403 +36%
Goldman Sachs
43
Goldman Sachs
New York
$25.1M +$1.35M +24,974 +7%
Ensign Peak Advisors
44
Ensign Peak Advisors
Utah
$24.3M -$2.7M -50,028 -12%
ACM
45
Ashford Capital Management
Delaware
$23.9M +$1.69M +31,220 +10%
GT
46
Glenmede Trust
Pennsylvania
$21.5M +$12.5K +232 +0.1%
NIP
47
Nicholas Investment Partners
California
$21.2M +$17M +314,704 New
DDC
48
DF Dent & Co
Maryland
$20.5M +$5.11M +94,606 +45%
Principal Financial Group
49
Principal Financial Group
Iowa
$20.3M -$71.8K -1,330 -0.4%
SCA
50
Summit Creek Advisors
Minnesota
$20.1M +$63.5K +1,176 +0.4%

HQY Hedge Fund Activity: Q1 2022 in Review

298 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in HealthEquity (HQY) for Q1 2022, worth a combined $5.63B — up 56% from $3.6B a quarter earlier.

Buyers outnumbered sellers: 64 funds opened new HQY positions and 44 closed out — a net gain of 20 holders — while 110 added to existing stakes and 94 trimmed.

The largest buyer was Millennium Management, adding an estimated $53.4M. The largest seller was Loomis, Sayles & Company, exiting entirely with an estimated $24.8M sold.

  • 298 institutional investors held HealthEquity (HQY) as of Q1 2022, up from 282 in Q4 2021.
  • Funds reported $5.63B of HealthEquity stock for Q1 2022, up 56% quarter-over-quarter.
  • 64 funds opened new HealthEquity positions in Q1 2022 and 44 closed out, a net change of +20 holders.
  • The largest HealthEquity buyer in Q1 2022 was Millennium Management, an estimated $53.4M added.
  • The largest HealthEquity seller in Q1 2022 was Loomis, Sayles & Company, an estimated $24.8M sold.

Based on aggregated 13F filings for Q1 2022.